Kinematic and Neural Dynamics of Postural Instability in Parkinson's Disease Trial N/A Recruiting Nov. 2, 2025
A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease Trial Phase 2 Completed Oct. 30, 2025
Perilead Edema in Deep Brain Stimulation: Long-Term Outcomes and Etiologic Correlates. Research Neuromodulation : journal of the International Neuromodulation Society Oct. 30, 2025
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease Trial Phase 1 Terminated Oct. 28, 2025
Sociodemographic determinants and comorbidities associated with polypharmacy among the adult population in Korea: a nationwide claim analysis. Research Korean journal of family medicine Oct. 28, 2025
Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE) Trial Phase 1 Active, not recruiting Oct. 27, 2025
Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS Trial Phase 1 Active, not recruiting Oct. 27, 2025
Analysis and Suppression of Tremor During Grasp Using Ultrasound Imaging and Electrical Stimulation Trial N/A Completed Oct. 26, 2025
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: Trial N/A Recruiting Oct. 21, 2025
Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease Trial N/A Enrolling by invitation Oct. 21, 2025
Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes Trial Phase 2 Terminated Oct. 20, 2025
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD Trial N/A Recruiting Oct. 14, 2025
Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait Using Neural and Kinematic Feedback Trial N/A Completed Oct. 14, 2025
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. Trial Phase 2 Not yet recruiting Oct. 14, 2025
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis Trial Phase 2 Recruiting Oct. 13, 2025
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Trial Phase 1 Recruiting Oct. 13, 2025